Introduction
In previous studies, we have used existing genetic epidemiological data on AAT Deficiency collected by others and published in the peer-reviewed medical literature on 69 countries worldwide both to develop estimates of the prevalence of these two deficiency alleles and to use them to obtain estimates of the percentages of the total population in each country in each of the five major deficiency phenotypic classes, namely: PI MS, PI MZ, PI SS, PI SZ and PI ZZ. This present analysis has made use of the most recent estimates of the total population of each country and our es- cy. The present study provides estimates of the numbers at risk for AAT Deficiency in these 25 countries in the Caribbean, and North, Central and South America. as well as providing an update on the numbers at risk in Canada and the United States as described earlier.
This unique database of AAT Deficiency in these 94 countries worldwide has resulted in estimates of the numbers at risk in each of these countries for a particular human genetic disease. We also have compared the numbers in each of these five phenotypic classes of the total populations from one country to another and demonstrated striking differences among countries in the same geographic region in the Caribbean, North, Central and South America. Such information is critical for a better understanding of the spread of this disease into different counties worldwide.
The prevalence data for these 94 countries suggests that AAT deficiency may be one of the most common serious single-locus human genetic diseases in the world. It is not a rare disorder, but a human disease that is relatively unknown and as a result is too rarely diagnosed and treated.
Methods

Estimates of the total population in each country
Estimates of the total population of each country as of July 2008 were obtained from the CIA FactBook site (https://www.cia.gov/cia/publications/ factbook/index.html).
Source of the estimates genetic epidemiological studies for PI S, and PI Z, and estimates of the prevalences for each of these two major deficiency alleles
Estimates of the percentages of the PI S and PI Z alleles in different ethnic subgroups were made as illustrated in tables 1 and 2 using data both from the present and our previous studies on African, European and Asian cultures as well as genetic epidemiological studies on various genetic subgroups indigenous to the Caribbean and North, Central and South America.
Allele frequencies of PI M, PI S, and PI Z in these 25 countries were estimated as follows: The gene frequencies of the PI S and PI Z deficiency alleles in these different ethnic populations were used to develop formulas to obtain estimates of the number of the PI S and PI Z alleles in hypothetical populations of 1,000 individuals in each of these 25 countries. These formulas, which varied from country to country, took into account the differences in the ethnic compositions as well as the frequencies of the PI S and PI Z alleles in each of these ethic subgroups as illustrated in table 1. All of these estimates were then extrapolated to theoretical populations of 3,000 individuals in each country as follows:
The ethnic subgroup composition of each country and estimates of size (%) of each was used to obtain estimates of the numbers of PI S ad PI Z alleles found for each of these 25 countries as given in table 2.
Results
In table 3, The number of the PI S and PI Z deficiency alleles in these theoretical populations of 3,000 individuals were then used to estimate the numbers in each of five phenotypic classes: PI MS, PI MZ, PI MS, PI SZ and PI ZZ in each of the 25 countries in the Caribbean, and North, Central, and South America using methods described in our earlier publications. These estimates of the numbers in each of five phenotypic classes: PI MS, PI MZ, PI MS, PI SZ and PI ZZ with 95% confidence intervals for these 25 countries are grouped into 6 major geographic regions. This makes it possible to compare the estimates for each of the countries within a given geographic region as in our earlier publication on 69 countries worldwide.
Comparison of the numbers in each of the five phenotypic classes of PI S ad PI Z in each of 25 countries in the Caribbean and North, Central and South America grouped into 6 geographic regions
The final comparisons in table 4 were made between the numbers in each of the each of five phenotypic classes: PIMS, PIMZ, PI MS, PI SZ and PIZZ in each of the six geographic regions in the Caribbean and North, Central, and South America. Using Hardy-Weinberg statistical analysis, each estimate is given along with 95% confidence intervals. This tabulation makes it possible to compare the numbers in each of these five phenotypic classes both between countries in the same geographic region as well as between different geographic regions.
In table 4, the data for each of the 6 geographic regions are given along with a summary for all of the 25 countries collated as a summary for this portion of the 25 countries in the Caribbean and North, Central, and South America. Of particular interest are the estimates of 25,452,217 for phenotype PI The results of the present analysis of AAT Deficiency in North and South America clearly indicate that this disease is present in all of these 25 different populations. The present prevalences of the PI S and PI Z deficiency alleles are most probably the result of emigration to these countries from Portugal and Spain with minor contributions in some countries from emigration of populations from several countries in Africa, as well as other countries such as Italy, Germany or France.
Discussion
The primary objective of the present analysis is to demonstrate that the two major deficiency alleles of AAT Deficiency are in widespread distribution worldwide and to expand our original analysis for 69 countries in Asia, Africa, Australia/New Zealand and Europe and North America to 25 countries in the Caribbean and North, Central and South America.
In countries colonized by Europeans in Mexico, the Caribbean and North, Central and South America, PI S and PI Z frequencies are a reflection of the immigrant European Caucasian population frequency (predominantly Spanish and Portuguese with fewer Italian and German immigrants, with high and intermediate values of both genes). Both of the PI S and PI Z alleles are rare or non-existent in Amerindians.
Absent from the peer-reviewed medical literature are detailed studies on genetic epidemiology of AAT Deficiency in different parts of the countries in the current 25 country database as well as precise information on the ethnic composition of the populations studied. This paucity of the genetic epidemiological studies in many regions of a given country makes it impossible, for example, to perform the type of analysis that we reported earlier on 14/20 regions in Italy to investigate the possibility of regional differences within a given country due to the differences in the genetic makeup of the original settlers.
Comparison of the prevalence of the PI S and PI Z deficiency alleles among countries within a given geographic region
By combining the data in table 3 of the numbers of the total population for each of these 25 countries in each of the five phenotypic classes of PI S and PI Z, it makes it possible to compare their prevalence among countries in close proximity. It is evident from comparison of this prevalence in the countries that there can be marked differences in this prevalence between countries in the same geographic region.
In contrast to our previous studies on AAT Deficiency in 69 countries worldwide, both of these deficiency alleles were found in the 25 countries. However, the data in table 3 demonstrate the highest numbers of the PI ZZ phenotype were found in the Region 5 consisting of Brazil, Ecuador and Peru, followed by Regions 6 and 1. The highest number of the PI SS phenotype was also found in Region 5 followed by Regions 6 and 1.
In conclusion, the genetic epidemiological database on the prevalence of the two most common deficiency alleles PI S and PI Z has shown that they both exist in all of the 25 countries in the Caribbean and North, Central and South America. In most countries, individuals with phenotypes that put them at risk for various environmental exposures have not been identified as carriers of the Pi*S or PI*Z deficiency alleles There are cost effective targeted screening approaches that could be used, for example, on white COPD patients to detect such carriers, It is also possible that there is a high prevalence of AAT Deficiency alleles in patients with asthma.
Identification of individuals with AAT Deficiency is critical for management, education and treatment. AAT Deficiency patients comprise a highly susceptible subgroup that is sensitive to tobacco smoking, organic chemical, particulates, and microbes in the environment. It is reasonable to expect that risk could be quite high in particular occupations and professions.
In summary, It is clear that alpha 1-antitrypsin deficiency is not just a disease of Europeans emigrants in these 25 countries, but it also can be found (with a lower frequency) in the Mestizo and Mulatto ethnic subgroups in most of these countries. Unfortunately, it also is clear that most individuals who are carriers of this disease
have not yet been identified in any of these 25 countries.
